retatrutide phase 2 results 2024 2025 press release trial today New 3 retatrutide data just dropped 👀 Eli Lilly's trial reported The Retatrutide Dosage Chart

FDA approved a modified version of Ozempic (marketed as Wegovy, also from Novo Nordisk) for weight loss

Combined therapy with two classes of antidiabetic agents, namely, dipeptidyl peptidase 4 inhibitors and sodium-glucose co-transporter-2 inhibitors, target several pathophysiological pathways

Free to check with no pressure to commit Answer just a few quick questions No paperwork,...

Recently, the GLP-1 RA semaglutide was reported to reduce cardiovascular events in ASCVD patients with overweight or obesity even in the absence of diabetes mellitus

“In this multicenter study of over 250,000 hospitalizations, use of novel diabetes medications prior to discharge was rare, raising the concern for systematic underutilization

Stopping treatment with weight loss medications is associated with gradual weight gain and a loss of earlier improvements in heart and metabolic he